Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Carcinoma, Non-Small-Cell Lung 122 Squamous Cell Carcinoma of Head and Neck 60 Melanoma 57 Parkinson Disease 4, Autosomal Dominant Lewy Body 47 Lung Neoplasms 46 Triple Negative Breast Neoplasms 44 Neoplasm Metastasis 44 Breast Neoplasms 40 Neoplasms 38 Colorectal Neoplasms 33 Head and Neck Neoplasms 27 Carcinoma, Renal Cell 27 Endometrial Neoplasms 26 Carcinoma, Transitional Cell 24 Ovarian Neoplasms 23 Urinary Bladder Neoplasms 21 Stomach Neoplasms 16 Carcinoma 15 Pancreatic Neoplasms 14 Uterine Cervical Neoplasms 12 Recurrence 12 Esophageal Neoplasms 12 Sarcoma 11 Hodgkin Disease 11 Brain Neoplasms 11 Cholangiocarcinoma 10 Carcinoma, Squamous Cell 10 Carcinoma, Hepatocellular 9 Skin Neoplasms 8 Prostatic Neoplasms 8

Interventions

pembrolizumab 1 Platinum 1 Fluorouracil 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Solid Neoplasms × pembrolizumab × 90 days × Clear all

NCT04420884 2026-04-08

iintune-1

Takeda

Phase 1/2 Completed

Solid Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡